Dr. Heather Wakelee is the Faculty Director of the Stanford Cancer Clinical Trials Office as well as the Lead Investigator for ECOG-ACRIN Clinical Trials Group at Stanford. Dr. Wakelee specializes in the treatment of lung cancer, thymoma and mesothelioma. She is also active in many national and international organizations related to lung cancer and thymoma, including leadership roles in the International Association for the Study of Lung Cancer (IASLC) and the International Thymic Malignancies Interest Group (ITMIG). She is the principal investigator on numerous clinical trials. Dr. Wakelee is the physician lead for the thoracic malignancies clinical research group and has developed research programs related to lung cancer and thymoma across multiple areas including clinical trials, translation work and population sciences.